Marco Iraci Sareri

ORCID: 0000-0003-2433-4841 · 5 papers in corpus · active 2021-2025

Study types

  • article 1
  • letter 1
  • preprint 1
  • rct 1
  • review 1

Condition tags

  • endometriosis 5
  • chronic_pelvic_pain 3
  • dysmenorrhea 1
  • dyspareunia 1
letter 2025
Reply to 'Critical appraisal of "Comparison of combined oral contraceptives and dienogest for endometriosis-associated pain"'
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2025.113945
article 2024
Comparative study on the effects of combined oral contraceptives and dienogest in women with endometriosis‑associated chronic pelvic pain
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2024.11.015

OBJECTIVE: To compare the effects of five combined oral contraceptives (COCs) - ethinylestradiol (EE) 30 μg/dienogest (DNG) 2 mg, EE 20 μg/drospirenone (DRSP) 3 mg, 17β-estradiol (E2) 1.5 mg/nomegestrol acetate (NomAc) 2.5 mg,estetrol (E4) …

rct 2022
Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis‑associated chronic pelvic pain
BMC women's health ·doi:10.1186/s12905-022-01737-7

BACKGROUND: To evaluate the effects of a combined oral contraceptive containing 1.5 mg 17b-estradiol (E2) and 2.5 mg nomegestrol acetate (NOMAC) or 2 mg/daily dienogest (DNG) oral progestin on endometriosis-associated chronic pelvic pain (C…

preprint 2022
Randomized Study on the Effectiveness of Nomegestrol Acetate Plus 17β-Estradiol Oral Contraceptive vs Dienogest Oral Pill in Women with Endometriosis‑Associated Chronic Pelvic Pain
·doi:10.21203/rs.3.rs-1323526/v1

Abstract Background: To evaluate the effects of a combined oral contraceptive containing 1.5mg 17b-estradiol (E2) and 2.5mg nomegestrol acetate (NOMAC) or 2 mg/daily dienogest (DNG) oral progestin on endometriosis-associated chronic pelvic …

review 2021
Clear cell degeneration associated with endometriosis of abdominal wall after cesarean section: A case report and systematic review of literature
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14635

AIM: The scar of cesarean section (CS) is the most common site of abdominal wall endometriosis (AWE), whose tumor degeneration has been reported in an increasing number of cases; the most frequent histological type is clear cell carcinoma (…